Issue 5/2017
Content (11 Articles)
Quality assurance guidelines for superficial hyperthermia clinical trials
Hana Dobšíček Trefná, Johannes Crezee, Manfred Schmidt, Dietmar Marder, Ulf Lamprecht, Michael Ehmann, Jacek Nadobny, Josefin Hartmann, Nicolleta Lomax, Sultan Abdel-Rahman, Sergio Curto, Akke Bakker, Mark D. Hurwitz, Chris J. Diederich, Paul R. Stauffer, Gerard C. Van Rhoon
Cosmetic changes following surgery and accelerated partial breast irradiation using HDR interstitial brachytherapy
Tamer Soror, György Kovács, Nina Seibold, Corinna Melchert, Kristin Baumann, Eike Wenzel, Suzana Stojanovic-Rundic
Better compliance with hypofractionation vs. conventional fractionation in adjuvant breast cancer radiotherapy
Volker Rudat, Alaa Nour, Mohamed Hammoud, Salam Abou Ghaida
Radical hypo-fractionated radiotherapy with volumetric modulated arc therapy in lung cancer
D. Franceschini, F. De Rose, L. Cozzi, P. Navarria, E. Clerici, C. Franzese, T. Comito, A. Tozzi, C. Iftode, G. D’Agostino, M. Sorsetti
Clinical relevance of the M1b and M1c descriptors from the proposed TNM 8 classification of lung cancer
Amanda Tufman, Kathrin Kahnert, Diego Kauffmann-Guerrero, Farkhad Manapov, Katrin Milger, Ullrich Müller-Lisse, Hauke Winter, Rudolf Maria Huber, Christian Schneider
Fully automated VMAT treatment planning for advanced-stage NSCLC patients
Giuseppe Della Gala, Maarten L. P. Dirkx, Nienke Hoekstra, Dennie Fransen, Nico Lanconelli, Marjan van de Pol, Ben J. M. Heijmen, Steven F. Petit
Framework for radiation pneumonitis risk stratification based on anatomic and perfused lung dosimetry
Gurleen Dhami, Jing Zeng, Hubert J. Vesselle, Paul E. Kinahan, Robert S. Miyaoka, Shilpen A. Patel, Ramesh Rengan, Stephen R. Bowen
Complementary and alternative medicine in radiation oncology
Sabrina Lettner, Kerstin A. Kessel, Stephanie E. Combs
Bei individualisierter und interdisziplinär abgewogener Behandlung intrakranieller Befunde dürfen Behandlungskosten kein primäres Entscheidungskriterium sein
Gerhard G. Grabenbauer, Stefan Glocker
Die Rolle der Beckenbestrahlung beim nodal-negativen Adenokarzinom der Prostata bleibt unklar
Matthias G. Hautmann, Oliver Kölbl
Vergleich der Kombination aus IMRT und IGRT mit konventioneller 3D-CRT bei der Bestrahlung des Prostatakarzinoms
Norbert Hodapp